PFM
Parsec Financial Management Portfolio holdings
AUM
$2.37B
This Quarter Return
-9.04%
1 Year Return
-4.66%
3 Year Return
+70.84%
5 Year Return
+68.38%
10 Year Return
+198.47%
AUM
$918M
AUM Growth
-$77.3M
(-7.8%)
Cap. Flow
+$18.9M
Cap. Flow
% of AUM
2.06%
Top 10 Holdings %
Top 10 Hldgs %
24.48%
Holding
182
New
8
Increased
90
Reduced
58
Closed
10
Top Buys
| 1 |
Duke Energy
DUK
|
$5.87M |
| 2 |
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
|
$3.26M |
| 3 |
Travelers Companies
TRV
|
$2.98M |
| 4 |
PayPal
PYPL
|
$2.72M |
| 5 |
Toronto Dominion Bank
TD
|
$2.6M |
Top Sells
| 1 |
Fifth Third Bancorp
FITB
|
$7.94M |
| 2 |
Medtronic
MDT
|
$5.46M |
| 3 |
SEI Investments
SEIC
|
$4.2M |
| 4 |
eBay
EBAY
|
$2.97M |
| 5 |
Alphabet (Google) Class C
GOOG
|
$1.99M |
Sector Composition
| 1 | Financials | 17.76% |
| 2 | Technology | 16.13% |
| 3 | Healthcare | 12.65% |
| 4 | Industrials | 9.2% |
| 5 | Consumer Staples | 7.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
iShares US Financials ETF
IYF
$4.04B
| $601K | 0.07% |
14,300
| – | – |
|
127
iShares Russell 2000 Value ETF
IWN
$11.8B
| $600K | 0.07% |
6,657
| – | – |
|
128
Merck
MRK
$209B
| $597K | 0.07% |
12,663
+1,654
| +15% | +$78K |
|
129
Schwab US Large-Cap Growth ETF
SCHG
$48.1B
| $570K | 0.06% |
91,160
+22,680
| +33% | +$142K |
|
130
Vanguard Russell 1000 Value ETF
VONV
$13.4B
| $542K | 0.06% |
13,270
+3,730
| +39% | +$152K |
|
131
Gilead Sciences
GILD
$140B
| $484K | 0.05% |
4,933
+1,534
| +45% | +$151K |
|
132
Dominion Energy
D
$50.5B
| $476K | 0.05% |
6,760
| – | – |
|
133
Philip Morris
PM
$254B
| $455K | 0.05% |
5,732
+290
| +5% | +$23K |
|
134
Novartis
NVS
$249B
| $431K | 0.05% |
5,231
| – | – |
|
135
Altria Group
MO
$113B
| $420K | 0.05% |
7,723
-8
| -0.1% | -$435 |
|
136
Amazon
AMZN
$2.5T
| $413K | 0.05% |
16,120
+2,000
| +14% | +$51.2K |
|
137
Vanguard Mid-Cap ETF
VO
$86.8B
| $394K | 0.04% |
3,375
-166
| -5% | -$19.4K |
|
138
Vanguard Value ETF
VTV
$143B
| $388K | 0.04% |
5,051
| – | – |
|
139
Bristol-Myers Squibb
BMY
$96B
| $361K | 0.04% |
6,099
| – | – |
|
|
RDS.A
140
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $356K | 0.04% |
7,503
-150
| -2% | -$7.12K |
|
141
Energy Transfer Partners
ET
$60.5B
| $348K | 0.04% |
16,720
| – | – |
|
142
Novo Nordisk
NVO
$248B
| $344K | 0.04% |
12,680
+400
| +3% | +$10.9K |
|
143
Vanguard Growth ETF
VUG
$186B
| $333K | 0.04% |
3,318
-530
| -14% | -$53.2K |
|
144
AbbVie
ABBV
$375B
| $321K | 0.04% |
5,899
-183
| -3% | -$9.96K |
|
145
Thermo Fisher Scientific
TMO
$179B
| $317K | 0.03% |
2,596
+678
| +35% | +$82.8K |
|
146
Norfolk Southern
NSC
$62.3B
| $309K | 0.03% |
4,048
+632
| +19% | +$48.2K |
|
147
Energizer
ENR
$1.95B
| $307K | 0.03% |
+7,921
| New | +$307K |
|
148
Pfizer
PFE
$140B
| $305K | 0.03% |
10,244
-1,665
| -14% | -$49.6K |
|
149
McDonald's
MCD
$227B
| $293K | 0.03% |
2,970
+100
| +3% | +$9.87K |
|
150
Royce Value Trust
RVT
$1.93B
| $290K | 0.03% |
25,200
-3,800
| -13% | -$43.7K |
|